The company was founded in 2001 and is headquartered in Beijing. It is a pharmaceutical group enterprise integrating research and development of new drugs, drug production, distribution and sales. On December 24, 2020, Yuekang Pharmaceutical was listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange. The company's main business covers the entire pharmaceutical R&D, manufacturing, distribution and sales industry chain. The company's core products are ginkgo biloba extract injections, omeprazole enteric capsules, metformin hydrochloride extended-release tablets, etc. Corporate honors: China's top 100 pharmaceutical industry enterprises, nationally certified enterprise technology center, 2020 China's best pharmaceutical R&D product line industrial enterprise, etc.
相关临床试验
17
0 进行中
药物批准
172
批准总数
监管机构
1
监管机构数
成立时间
2001
Unknown
17
100.0%
暂无资讯文章